An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy

Condition:   Duchenne Muscular Dystrophy Interventions:   Drug: Casimersen;   Drug: Golodirsen Sponsor:   Sarepta Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials